Search

  • HOME
  • Search
Review
1737
Screening strategy for non-alcoholic fatty liver disease
Saisai Zhang, Lung-Yi Mak, Man-Fung Yuen, Wai-Kay Seto
Clin Mol Hepatol. 2023;29(Suppl):S103-S122.   Published online November 30, 2022
View: 4213   Download: 222  Web of Science: 12  Crossref: 14
Letter to the Editor
Effects of interleukin-17 inhibitors on hepatic fibrosis index in patients with psoriasis and metabolic dysfunction-associated fatty liver disease: Directed acyclic graphs
Saori Takamura, Yuichi Teraki, Eri Katayama, Takumi Kawaguchi, Machiko Kawaguchi, Dan Nakano, Tsubasa Tsutsumi, Sumiko Nagoshi, Takekuni Nakama, Takuji Torimura
Clin Mol Hepatol. 2022;28(2):269-272.   Published online February 15, 2022
View: 4622   Download: 312  Web of Science: 6  Crossref: 5
Editorial
1590
Metabolic disease as a risk of hepatocellular carcinoma
Naoshi Nishida
Clin Mol Hepatol. 2021;27(1):87-90.   Published online December 3, 2020
View: 4647   Download: 104  Web of Science: 10  Crossref: 11
Review
Beneficial effect of anti-diabetic drugs for nonalcoholic fatty liver disease
Kyung-Soo Kim, Byung-Wan Lee
Clin Mol Hepatol. 2020;26(4):430-443.   Published online August 14, 2020
View: 9589   Download: 473  Web of Science: 35  Crossref: 35
1 |

Clinical and
Molecular
Hepatology

Print ISSN: 2287-2728
Online ISSN: 2287-285X


Editorial Office
The Korean Association for the Study of the Liver
Room A1210, 53 Mapo-daero(MapoTrapalace, Dowha-dong), Mapo-gu, Seoul, 04158, Korea
TEL: +82-2-703-0051   FAX: +82-2-703-0071    E-mail: kasl@kams.or.kr
Copyright © The Korean Association for the Study of the Liver.         
COUNTER
TODAY : 1839
TOTAL : 1776764
Close layer